The Malaysian Reserve

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for ...

Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase ...